{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T04:09:07Z","timestamp":1781150947536,"version":"3.54.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2003,2,1]],"date-time":"2003-02-01T00:00:00Z","timestamp":1044057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,2,1]],"date-time":"2003-02-01T00:00:00Z","timestamp":1044057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2003,2,1]]},"DOI":"10.1038\/sj.leu.2402790","type":"journal-article","created":{"date-parts":[[2003,2,18]],"date-time":"2003-02-18T16:50:43Z","timestamp":1045587043000},"page":"334-338","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Treatment of SCID\/human B cell precursor ALL with anti-CD19 and anti-CD22 immunotoxins"],"prefix":"10.1038","volume":"17","author":[{"given":"L","family":"Herrera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Yarbrough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Ghetie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D B","family":"Aquino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E S","family":"Vitetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,2,18]]},"reference":[{"key":"BF2402790_CR1","first-page":"73","volume":"4","author":"MK Brenner","year":"1999","unstructured":"Brenner MK, Pinkel D . Cure of leukemia. Semin Hematol 1999; 4: 73\u201383.","journal-title":"Semin Hematol"},{"key":"BF2402790_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2165\/00128072-199901030-00004","volume":"1","author":"J Lilleyman","year":"1999","unstructured":"Lilleyman J . Chemotherapy of childhood lymphoblastic leukaemia: the first 50 years. Pediat Drugs 1999; 1: 197\u2013209.","journal-title":"Pediat Drugs"},{"key":"BF2402790_CR3","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1182\/blood.V82.9.2624.2624","volume":"82","author":"PL Amlot","year":"1993","unstructured":"Amlot PL, Stone MJ, Cunningham D, Fay J, Newman J, Collins R, May R, McCarthy M, Richardson J, Ghetie V, Ramilo O, Thorpe PE, Uhr JW, Vitetta ES . A phase I study of an anti-CD22-deglycosylated ricin a chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy. Blood 1993; 82: 2624\u20132633.","journal-title":"Blood"},{"key":"BF2402790_CR4","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1182\/blood.V85.12.3457.bloodjournal85123457","volume":"85","author":"E Sausville","year":"1995","unstructured":"Sausville E, Headlee D, Stetler-Stevenson M, Jaffe E, Solomon D, Figg W, Herdt J, Kopp W, Rager H, Steinberg S, Ghetie V, Schindler J, Uhr JW, Wittes RE, Vitetta ES . Continuous infusion of the anti-CD22 immunotoxin IgG-RFB4-SMPT-dgA in patients with B-cell lymphoma: a phase I study. Blood 1995; 85: 3457\u20133465.","journal-title":"Blood"},{"key":"BF2402790_CR5","first-page":"1302","volume":"6","author":"R Messmann","year":"2000","unstructured":"Messmann R, Vitetta ES, Headlee D, Senderowicz A, Figg W, Schindler J, Michiel D, Creekmore S, Steinberg S, Kohler D, Jaffe E, Stetler-Stevenson M, Chen H, Ghetie V, Sausville E . A phase I study of combination therapy with immunotoxins IgG-HD37-dgA and IgG-RFB4-dgA (combotox) in patients with refractory CD19(+), CD22(+) B-cell lymphoma. Clin Cancer Res 2000; 6: 1302\u20131313.","journal-title":"Clin Cancer Res"},{"key":"BF2402790_CR6","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1182\/blood.V88.4.1188.bloodjournal8841188","volume":"88","author":"MJ Stone","year":"1996","unstructured":"Stone MJ, Sausville E, Fay J, Headlee D, Collins R, Figg W, Stetler-Stevenson M, Jain V, Jaffe E, Solomon D, Lush R, Senderowicz A, Ghetie V, Schindler J, Uhr JW, Vitetta ES . A phase I study of bolus versus continuous infusion of the anti-CD19 immunotoxin, IgG-HD37-dgA, in patients with B-cell lymphoma. Blood 1996; 88: 1188\u20131197.","journal-title":"Blood"},{"key":"BF2402790_CR7","first-page":"4052","volume":"51","author":"ES Vitetta","year":"1991","unstructured":"Vitetta ES, Stone MJ, Amlot P, Fay J, May R, Till M, Newman J, Clark P, Collins R, Cunningham D . Phase I immunotoxin trial in patients with B-cell lymphoma. Cancer Res 1991; 51: 4052\u20134058.","journal-title":"Cancer Res"},{"key":"BF2402790_CR8","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/00002371-199511000-00004","volume":"18","author":"R Conry","year":"1996","unstructured":"Conry R, Khazaeli MB, Saleh M, Ghetie V, Vitetta ES, Liu T, LoBuglio A . A phase I trial of an anti-CD19 deglycosylated ricin a chain immunotoxin in non-Hodgkin\u2019s lymphoma: effect of an intensive schedule of administration. J Immunother 1996; 18: 231\u2013241.","journal-title":"J Immunother"},{"key":"BF2402790_CR9","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/sj.leu.2401779","volume":"5","author":"L Herrera","year":"2000","unstructured":"Herrera L, Farah R, Pellegrini VA, Aquino DB, Buchanan GR, Vitetta ES . Immunotoxins against CD19 and CD22 are effective in killing precursor-B acute lymphoblastic leukemia cells in vitro. Leukemia 2000; 5: 853\u2013858.","journal-title":"Leukemia"},{"key":"BF2402790_CR10","first-page":"2610","volume":"48","author":"M Ghetie","year":"1988","unstructured":"Ghetie M, May RD, Till M, Uhr JW, Ghetie V, Knowles PP . Evaluation of ricin-a chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy. Cancer Res 1988; 48: 2610\u20132617.","journal-title":"Cancer Res"},{"key":"BF2402790_CR11","first-page":"253","volume":"165","author":"B Dorken","year":"1983","unstructured":"Dorken B, Moldenhauer G, Schwartz R, Pezzutto A . B-cell differentiation antigens identified by monoclonal antibodies. Immunobiol 1983; 165: 253\u2013254.","journal-title":"Immunobiol"},{"key":"BF2402790_CR12","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/ijc.2910420527","volume":"42","author":"S Guo-Liang","year":"1988","unstructured":"Guo-Liang S, Jia-Ling L, Ghetie M, Ghetie V, May R, Till M, Brown A, Relf M, Knowles PP, Uhr JW, Janossy G, Amlot P, Vitetta ES, Thorpe PE . Evaluation of four CD22 antibodies as ricin A-chain-containing immunotoxins for the in vivo therapy of anti-human B-cell leukemias and lymphomas. Int J Cancer 1988; 42: 792\u2013797.","journal-title":"Int J Cancer"},{"key":"BF2402790_CR13","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.4049\/jimmunol.134.3.1524","volume":"134","author":"D Campana","year":"1985","unstructured":"Campana D, Janossy G, Bofill M, Trejdosiewicz LK, Ma D, Hoffbrand AV, Mason DY, LeBacq AM, Forster HK . Human B-cell development I. Phenotypic differences of B lymphocytes in the bone marrow and peripheral lymphoid tissue. J Immunol 1985; 134: 1524\u20131529.","journal-title":"J Immunol"},{"key":"BF2402790_CR14","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1182\/blood.V80.9.2315.2315","volume":"80","author":"M Ghetie","year":"1992","unstructured":"Ghetie M, Tucker K, Richardson J, Uhr JW, Vitetta ES . The antitumor activity of an anti-CD22 immunotoxin in SCID mice with disseminated daudi lymphoma is enhanced by either an anti-CD19 antibody or an anti-CD19 immunotoxin. Blood 1992; 80: 2315\u20132320.","journal-title":"Blood"},{"key":"BF2402790_CR15","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1182\/blood.V79.9.2201.2201","volume":"79","author":"FM Uckun","year":"1992","unstructured":"Uckun FM, Manivel C, Arthur D, Chelstrom L, Finnegan D, Tuel-Ahlgren L, Irvin JD, Myers D, Gunther R . In vivo efficacy of B43 (anti-CD19)-pokeweed antiviral protein immunotoxin against human pre-B cell acute lymphoblastic leukemia in mice with severe combined immunodeficiency. Blood 1992; 79: 2201\u20132214.","journal-title":"Blood"},{"key":"BF2402790_CR16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1089\/cbr.1997.12.177","volume":"12","author":"A Demidem","year":"1997","unstructured":"Demidem A, Lam T, Alas S, Hariharan K, Hanna N, Bonavida B . Chimeric anti-CD20 (IDEC-C2B8) monoclonal antibody sensitizes a B-cell lymphoma cell line to cell killing by cytotoxic drugs. Cancer Biother Radiopharm 1997; 12: 177\u2013186.","journal-title":"Cancer Biother Radiopharm"},{"key":"BF2402790_CR17","first-page":"255","volume":"7","author":"J Schindler","year":"2001","unstructured":"Schindler J, Sausville E, Messmann R, Uhr JW, Vitetta ES . The toxicity of deglycosylated ricin A chain-containing immunotoxins in patients with non-Hodgkin\u2019s lymphoma is exacerbated by prior radiotherapy: a retrospective analysis of patients in five clinical trials. Clin Cancer Res 2001; 7: 255\u2013258.","journal-title":"Clin Cancer Res"},{"key":"BF2402790_CR18","first-page":"3402","volume":"52","author":"T Yokota","year":"1992","unstructured":"Yokota T, Milenic DE, Whitlow M, Schlom J . Rapid tumor penetration of a single-chain fv and comparison with other immunoglobulin forms. Cancer Res 1992; 52: 3402\u20133408.","journal-title":"Cancer Res"},{"key":"BF2402790_CR19","volume-title":"CD19 workshop panel report. In: Koshimoto T, Kikkutani H, Kr.non dem Borne AEG, Goyert SM, Mason DY, Meyasaka M, Moretta L, Okumura K, Shaw S, Springer TA, Sogamura K, Zola H (eds). Leukocyte Typing VI White Cell Differentiation Antigens, vol 6. Garland Pu","author":"S Sato","year":"1997","unstructured":"Sato S, Tedder TF . CD19 workshop panel report. In: Koshimoto T, Kikkutani H, Kr.non dem Borne AEG, Goyert SM, Mason DY, Meyasaka M, Moretta L, Okumura K, Shaw S, Springer TA, Sogamura K, Zola H (eds). Leukocyte Typing VI White Cell Differentiation Antigens, vol 6. Garland Publishing Inc, : New York (1997."},{"key":"BF2402790_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4612-4848-4_1","volume-title":"Leukocyte Typing II","author":"LM Nadler","year":"1986","unstructured":"Nadler LM . B cell\/leukemia panel workshop: summary and comments. In: Reinherz EL, Haynes BF, Nadler LM, Bernstein ID (eds) Leukocyte Typing II, vol. 2, Springer Verlag: New York 1986. p 3."},{"key":"BF2402790_CR21","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1182\/blood.V84.3.702.702","volume":"84","author":"M Ghetie","year":"1994","unstructured":"Ghetie M, Tucker K, Richardson J, Uhr JW, Vitetta ES . Eradication of minimal disease in severe combined immunodeficient mice with disseminated daudi lymphoma using chemotherapy and an immunotoxin cocktail. Blood 1994; 84: 702\u2013707.","journal-title":"Blood"},{"key":"BF2402790_CR22","first-page":"2610","volume":"48","author":"M Ghetie","year":"1998","unstructured":"Ghetie M, May R, Till M, Uhr JW, Ghetie V, Knowles PP, Relf M, Brown M, Wallace PM, Janossy G, Amlot P, Vitetta ES, Thorpe PE . Evaluation of ricin A-chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B cells as potential reagents for in vivo therapy. Cancer Res 1998; 48: 2610\u20132617.","journal-title":"Cancer Res"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2402790.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402790","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402790.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T04:12:30Z","timestamp":1704773550000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2402790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2,1]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,2,1]]}},"alternative-id":["BF2402790"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2402790","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,2,1]]},"assertion":[{"value":"21 February 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}